WallStreetZenWallStreetZen

NASDAQ: CELU
Celularity Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their CELU stock forecasts and price targets.

Forecast return on equity

Is CELU forecast to generate an efficient return?
Company
N/A
Industry
77.48%
Market
83.08%

Forecast return on assets

Is CELU forecast to generate an efficient return on assets?
Company
N/A
Industry
31.32%

CELU revenue growth forecast

How is CELU forecast to perform vs Biotechnology companies and vs the US market?
Company
73.55%
Industry
35.01%
Market
9.94%
CELU's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CELU's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CELU vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CELU$2.98N/AN/A
RLYB$1.40$8.90+535.71%Buy
NTRB$5.19N/AN/A
CLGN$5.10$11.00+115.69%Buy
GNTA$3.23$25.00+675.19%Buy

Celularity Stock Forecast FAQ

What is CELU's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: CELU) forecast ROE is N/A, which is considered weak.

If you're new to stock investing, here's how to buy Celularity stock.

What is CELU's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: CELU) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 31.32%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.